Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma

AIMS: To evaluate the expression of DSG1 and DSG2 and investigate their clinicopathological significance in EHCC. METHOD: The protein expression of DSG1 and DSG2 was measured by EnVision immunohistochemistry in 15 normal biliary tract tissues, 10 biliary tract adenoma tissues, 30 peritumoral tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shu, Huang, Shengfu, Li, Daiqiang, Zou, Qiong, Yuan, Yuan, Yang, Zhulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436288/
https://www.ncbi.nlm.nih.gov/pubmed/32850288
http://dx.doi.org/10.1155/2020/9831646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436288/
https://www.ncbi.nlm.nih.gov/pubmed/32850288
http://dx.doi.org/10.1155/2020/9831646

Ejemplares similares